University Of Pittsburgh Scientists Find Biological Clue To Why Ex-Smokers Develop Lung Cancer Many Years After Quitting

August 21, 1997

PITTSBURGH, Aug. 5 -- Smoking for at least 25 years appears to trigger a biological switch that drives the growth of lung cells. Once set in motion, this process could lead to cancer, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) in a report published in the August issue of the Journal of Respiratory and Critical Care Medicine.

"We believe that this switch is a smoking-related indicator of lung cancer risk because we see it activated in most individuals with a long history of smoking, regardless of whether they already have developed cancer," said Jill Siegfried, Ph.D., associate professor of pharmacology at the University of Pittsburgh School of Medicine and director of basic science at the University of Pittsburgh Cancer Institute's Lung Cancer Center.

"Once this switch is turned on, it appears to be permanent, which may explain in part why long-term ex-smokers who have not had a cigarette in over 25 years are still at high risk for getting lung cancer. Knowing when this switch appears in someone's lung could help clinicians administer chemopreventive drugs to avert the final transformation of these cells into cancer. Better still, if we can turn off this switch, we might significantly reduce the odds that an ex-smoker will ever get lung cancer," she added.

The "switch" is gastrin-releasing peptide (GRP) receptor, a protein that appears on the surface of lung cells in people with lengthy smoking histories (a pack or more a day for at least 25 years). When present, GRP receptors capture nearby circulating hormones (bombesin-like peptides, or BLPs), which are normally important for maturation of fetal lungs and which spur lung cells to divide in the mature organ. After the GRP receptor appears in an ex-smoker's lung, new clusters of lung cells form. These new cells, in turn, may continue to express GRP receptors which capture more BLPs in a self-perpetuating cycle leading to the unrestrained growth of lung tissue.

In their study, the investigators looked at cells lining the lungs of 37 subjects, some who were nonsmokers, some who had smoked less than 25 years and others who had smoked 25 years or longer. Only 14.7 percent of those who smoked less than 25 years expressed the GRP receptor, whereas 77 percent of those who smoked more than 25 years expressed the GRP receptor, even if they had stopped smoking some time ago. "This shows that the duration of smoking, not just whether someone smoked, is critical to expressing the GRP receptor," said Dr. Siegfried. The researchers also found that lung cells taken from patients who had chronic obstructive lung disease had a greater tendency to respond to BLPs; in other words, they grew considerably more than lung cells from individuals without this disorder in the presence of the same level of BLPs. Chronic obstructive lung disease is usually caused by long-term smoking, and it increases the risk for lung cancer.

"This finding also suggests that the GRP receptor switch in patients with chronic obstructive lung disease is more sensitive than in people without this lung disorder."

"Our study is an important first step. We are currently conducting a large-scale study of smokers and nonsmokers to confirm these findings and expand our understanding of the steps between smoking and the development of lung cancer, which is a very complex process," added Dr. Siegfried.


For additional information about the University of Pittsburgh Medical Center or the University of Pittsburgh Cancer Institute, please access the website Pitt's website for the department of pharmacology is

University of Pittsburgh Medical Center

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to